Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

Cited by (487)

Items 201–300 of 487

1. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression
   Narumol Bhummaphan, Nalinrat Petpiroon, Ornjira Prakhongcheep, Boonchoo Sritularak, Pithi Chanvorachote B · 2019 · Phytomedicine
2. Susceptibility of Signal Transducer and Activator of Transcription-1-Deficient Mice to Pulmonary Fibrogenesis
   Dianne M. Walters, Aurita Antao-Menezes, Jennifer L. Ingram, Annette B. Rice, Abraham Nyska, Yoshiro Tani, Steven R. Kleeberger, James C. Bonner · 2005 · American Journal Of Pathology
3. STAT3 in tissue fibrosis: Is there a role in the lung?
   Darryl A. Knight, Steven Eugene Mutsaers, Cecilia M. Prêle · 2010 · Pulmonary Pharmacology & Therapeutics
4. Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles
   Laurence Veracini, Mélanie Franco, Anthony Boureux, Valérie Simon, Serge Roche, Christine Bénistant · 2006 · Journal of Cell Science
5. Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.
   S. Ihara, H. Kida, H. Arase, L. Tripathi, Yi-An Chen, Tetsuya Kimura, Mitsuhiro Yoshida, Yozo Kashiwa, H. Hirata, Reiko Fukamizu et al. · 2012 · Cancer Research
6. STAT3: A Central Mediator of Pulmonary Fibrosis?
   Cecilia M. Prêle, Eric Yao, Robert J.J. O’Donoghue, Steven Eugene Mutsaers, Darryl A. Knight · 2012 · Proceedings of the American Thoracic Society
7. Indirubin-3′-Monoxime Blocks Vascular Smooth Muscle Cell Proliferation by Inhibition of Signal Transducer and Activator of Transcription 3 Signaling and Reduces Neointima Formation In Vivo
   Andrea V. Schwaiberger, Elke H. Heiß, Muris Cabaravdic, Tina Blažević, Jan Zaujec, Daniel Schachner, Pavel Uhrín, Atanas G. Atanasov, Johannes M. Breuss, Bernd R. Binder et al. · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
8. c‐myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3
   Kate D. Sutherland, François Vaillant, Warren S. Alexander, Tim M Wintermantel, Natasha C. Forrest, Sheridan L Holroyd, Edward J. McManus, Günther Schütz, Christine J. Watson, Lewis A. Chodosh et al. · 2006 · The EMBO Journal
9. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src
   John de Groot, Vanessa C. Milano · 2009 · Journal of Neuro-Oncology
10. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
    Hai-Feng Zhang, Ye Chen, Chengsheng Wu, Zhi-Yong Wu, David John Tweardy, Abdulraheem Alshareef, Lian‐Di Liao, Yu-Jie Xue, Jian-Yi Wu, Bo Chen et al. · 2015 · Clinical Cancer Research
11. Long noncoding RNA H19 competitively binds miR‐93‐5p to regulate STAT3 expression in breast cancer
    Jia‐Peng Li, Yuan Xiang, Li‐Juan Fan, Ao Yao, Hui Li, Xing‐Hua Liao · 2018 · Journal of Cellular Biochemistry
12. Tensile force-induced PDGF-BB/PDGFRβ signals in periodontal ligament fibroblasts activate JAK2/STAT3 for orthodontic tooth movement
    Yuqin Jin, Liang Ding, Zhuang Ding, Yong Fu, Yuxian Song, Yue Jing, Qiang Li, Jianyun Zhang, Yanhong Ni, Qingang Hu · 2020 · Scientific Reports
13. Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors
    Anthony Boureux, Olivia Furstoss, Valérie Simon, Serge Roche · 2005 · Journal of Cell Science
14. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells
    Bohye Park, Joo Weon Lim, Hyeyoung Kim · 2018 · Nutrition Research
15. Diminished Expression of Corticotropin-Releasing Hormone Receptor 2 in Human Colon Cancer Promotes Tumor Growth and Epithelial-to-Mesenchymal Transition via Persistent Interleukin-6/Stat3 Signaling
    Jorge A. Rodriguez, Sara Huerta‐Yépez, Ivy Ka Man Law, Guillermina Juliana Baay-Guzman, Belén Tirado-Rodríguez, Jill M. Hoffman, Dimitrios Iliopoulos, Daniël W. Hommes, Hein W. Verspaget, Lin Chang et al. · 2015 · Cellular and Molecular Gastroenterology and Hepatology
16. Suppression of v-Src Transformation by Andrographolide via Degradation of the v-Src Protein and Attenuation of the Erk Signaling Pathway
    Fong-Pin Liang, Chao Lin, Cheng‐Deng Kuo, Hsueh‐Ping Chao, Shu-Ling Fu · 2007 · Journal of Biological Chemistry
17. Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
    Hsing-Jien Kung · 2010 · Hormones and Cancer
18. Gambogic Acid Inhibits STAT3 Phosphorylation Through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis
    S. Prasad, M. Pandey, V. Yadav, B. Aggarwal · 2011 · Cancer Prevention Research · Retracted
19. Making Myc
    J. Liu, David Levens · 2006 · Current topics in microbiology and immunology
20. Phospho‐Stat3 expression and correlation with VEGF, p53, and Bcl‐2 in gastric carcinoma using tissue microarray
    JUNG‐HYE CHOI, Myung‐Ju Ahn, CHAN‐KUM PARK, Hongxiu Han, Sung-Joon Kwon, YOUNG‐YUEL LEE, I. S. Kim · 2006 · Apmis
21. PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility
    C Zhou, Y Tong, Kolja Wawrowsky, Shlomo K. Melmed · 2013 · Oncogene
22. Cross-regulation of JAK and Src kinases
    Evan Ingley, S. Peter Klinken · 2006 · Growth Factors
23. Role of LIM Kinases in Normal and Psoriatic Human Epidermis
    Masaru Honma, Salvador Aznar Benitah, Fiona M. Watt · 2006 · Molecular Biology of the Cell
24. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion
    Mukhopadhyay, Utpal K., Mooney, Patrick, Jia, Lilly, Eves, Robert, Raptis, Leda, Mak, Alan S. · 2010 · Molecular and Cellular Biology
25. SRC Signaling in Cancer and Tumor Microenvironment
    Ayşe Caner, Elif Aşık, Bülent Özpolat · 2020 · Advances in experimental medicine and biology
26. Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways
    Xi Zhang, Hui Xu, Xiaoyang Bi, Guoqing Hou, Andong Liu, Youyun Zhao, Guoping Wang, Xuan Cao · 2021 · Cell Death and Disease
27. c-Yes regulates cell adhesion at the apical ectoplasmic specialization-blood-testis barrier axis via its effects on protein recruitment and distribution
    Xiang Xiao, Dolores D. Mruk, C. Yan Cheng · 2012 · American Journal of Physiology-Endocrinology and Metabolism
28. Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice
    Tatsuaki Tsuruyama, Takuro Nakamura, Guang Jin, Munetaka Ozeki, Yoshihiro Yamada, Hiroshi Hiai · 2002 · Proceedings of the National Academy of Sciences
29. The Adaptor Protein Tom1L1 Is a Negative Regulator of Src Mitogenic Signaling Induced by Growth Factors
    Mélanie Franco, Olivia Furstoss, Valérie Simon, C. Benistant, Wan Jing Hong, Serge Roche · 2006 · Molecular and Cellular Biology
30. Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line
    Jeffrey D. Bjorge, Andy Pang, Melanie Funnell, Ke Yun Chen, Román Diaz, Anthony M. Magliocco, Donald J. Fujita · 2011 · PLoS ONE
31. Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
    Fabrizio Marcucci, Cristiano Rumio, François Lefoulon · 2016 · Frontiers in Oncology
32. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence
    Kalyan Reddy Manda, P Tripathi, Andy C. Hsi, Jie Ning, Marianna B. Ruzinova, Helen Liapis, Matthew H. Bailey, H Zhang, Christopher A. Maher, Peter A. Humphrey et al. · 2015 · Oncogene
33. Molecular Cloning and Characterization of the Human AKT1 Promoter Uncovers Its Up-regulation by the Src/Stat3 Pathway
    Sungman Park, Donghwa Kim, Satoshi Kaneko, Kristen M. Szewczyk, Santo V. Nicosia, Hua Yu, Richard Jove, Jin Quan Cheng · 2005 · Journal of Biological Chemistry · Retracted
34. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells
    Aki Tanouchi, Keisuke Taniuchi, Mutsuo Furihata, Seiji Naganuma, Ken Dabanaka, Masashi Kimura, Ryohei Watanabe, Takuhiro Kohsaki, Takahiro Shimizu, Motoaki Saito et al. · 2016 · Journal of Experimental & Clinical Cancer Research
35. Signal Transducer and Activator of Transcription Factor 1 Mediates Apoptosis Induced by Hepatitis C Virus and HIV Envelope Proteins in Hepatocytes
    Anuradha Balasubramanian, Ramesh Kumar Ganju, Jerome E. Groopman · 2006 · The Journal of Infectious Diseases
36. Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution
    Qingfei Jiang, Jane Marie Isquith, Luisa Ladel, Adam Mark, Frida Holm, Cayla N. Mason, Yudou He, Phoebe K. Mondala, Isabelle Oliver, Jessica Pham et al. · 2021 · Cell Reports
37. MRTF-A and STAT3 synergistically promote breast cancer cell migration
    Xing‐Hua Liao, Nan Wang, Long–Yue Liu, Zheng Li, Wenjing Xing, Dongwei Zhao, Xueguang Sun, Peng Hu, Jian Dong, Tong‐Cun Zhang · 2014 · Cellular Signalling
38. MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
    Sarmistha Talukdar, Swadesh Kumar Das, Anjan K. Pradhan, Luni Emdad, Jolene J. Windle, Devanand Sarkar, Paul B. Fisher · 2019 · Cancers
39. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth
    Stella Pelengaris, Mike Khan · 2003 · Expert Opinion on Therapeutic Targets
40. Knockdown of the co-chaperone Hop promotes extranuclear accumulation of Stat3 in mouse embryonic stem cells
    Victoria M. Longshaw, Melissa A. Baxter, Marina C. Prewitz, Gregory L. Blatch · 2008 · European Journal of Cell Biology
41. Dynamin Inhibitors Impair Endocytosis and Mitogenic Signaling of PDGF
    Łukasz Sadowski, Kamil Jastrzębski, Yannis L. Kalaidzidis, Carl‐Henrik Heldin, Carina B. Hellberg, Marta Miączyńska · 2013 · Traffic
42. Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Jeong Won Park, Li Zhao, Sheue-yann Cheng · 2013 · Europe PMC (PubMed Central)
43. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation
    Megumi Funakoshi‐Tago, Kenji Tago, 千穂 西澤, Kyôko Takahashi, Tadahiko Mashino, Susumu Iwata, Hideo Inoue, Yoshiko Sonoda, Tadashi Kasahara · 2008 · Biochemical Pharmacology
44. Activated Src abrogates the Myc requirement for the G 0 /G 1 transition but not for the G 1 /S transition
    Tulsiram Prathapam, Sarah B. Tegen, Thórdur Óskarsson, Andreas Trumpp, G. Steven Martin · 2006 · Proceedings of the National Academy of Sciences
45. Stat3: Linking inflammation to (gastrointestinal) tumourigenesis
    Matthias Ernst, Tracy L. Putoczki · 2011 · Clinical and Experimental Pharmacology and Physiology
46. The impact of phosphatases on proliferative and survival signaling in cancer
    Goutham Narla, Jaya Sangodkar, Christopher B. Ryder · 2018 · Cellular and Molecular Life Sciences
47. Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology
    Mary E. Loveless, Deborah Lawson, Michael P. Collins, Murali V.P. Nadella, Corinne Reimer, Dennis Huszar, Jane L. Halliday, John C. Waterton, John C. Gore, Thomas E. Yankeelov · 2012 · Neoplasia
48. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC
    Liang‐Ru Ke, Yan‐Qun Xiang, Xiang Guo, Jinping Lu, Wei‐Xiong Xia, Ya‐Hui Yu, Yong‐Jian Peng, Li Wang, Gang Wang, Yan‐Fang Ye et al. · 2016 · Oncotarget
49. Phosphatase of Regenerating Liver 3 (PRL3) Provokes a Tyrosine Phosphoproteome to Drive Prometastatic Signal Transduction
    Chad D. Walls, Anton B. Iliuk, Yunpeng Bai, Mu Wang, W. Andy Tao, Zhong‐Yin Zhang · 2013 · Molecular & Cellular Proteomics
50. SHP2 is required for BCR-ABL1-induced hematologic neoplasia
    Shengqing Stan Gu, Azin Sayad, Gordon Chan, Wentian Yang, Zhibin Lu, Carl Virtanen, Richard A. Van Etten, Benjamin G. Neel · 2017 · Leukemia
51. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells
    Alejandra M. Petrilli, Jeanine Garcia, Marga Bott, Stephani Klingeman Plati, Christine Thuyvan Dinh, Olena R. Bracho, Denise Lu Shun Yan, Bing Zou, Rahul Mittal, Fred F. Telischi et al. · 2017 · Oncotarget
52. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease
    Qiang Gu, Yan Kong, Zubin Yu, Bai Li, Yingbin Xiao · 2011 · Biochimie
53. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma
    Jeong Hee Cho‐Vega, George Z. Rassidakis, Hesham M. Amin, Panagiota Tsioli, Kevin B. Spurgers, Yvonne K. Remache, Francisco Vega, Andre Henri Goy, Frédéric Gilles, Leonard Jeffrey Medeiros · 2004 · Leukemia
54. A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model
    Bryan Serrels, Alan Serrels, Susan M. Mason, Christine Baldeschi, G H S Ashton, Marta Canel, Lorna J. Mackintosh, Brendan J. Doyle, Tim P. Green, Margaret C. Frame et al. · 2008 · Carcinogenesis
55. FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
    Tianxiang Hu, Qing Wu, Yating Chong, Haiyan Qin, Candace J. Poole, Jan van Riggelen, Mingqiang Ren, John Kenneth Cowell · 2018 · Leukemia
56. The reactive oxygen species–Src–Stat3 pathway provokes negative feedback inhibition of apoptosis induced by high‐fluence low‐power laser irradiation
    Xuegang Sun, Shengnan Wu, Da Xing · 2010 · FEBS Journal
57. Zap70 Functions to Maintain Stemness of Mouse Embryonic Stem Cells by Negatively Regulating Jak1/Stat3/c-Myc Signaling
    Young Cha, Bo‐Hyun Moon, Mi-Ok Lee, Hee-Jin Ahn, Hye-Jin Lee, Kyung-ah Lee, Albert J. Fornace, Kwang‐Soo Kim, Hyuk‐Jin Cha, Kyung‐Soon Park · 2010 · Stem Cells
58. Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma
    Mingzhen Ying, Dawei Li, Linjun Yang, Mei Wang, Ning Wang, Ying Chen, Miaoxia He, Yajie Wang · 2010 · Journal of Cancer Research and Clinical Oncology
59. Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells
    Svenja Ebeling, Anita Kowalczyk, Diego Pérez-Vázquez, Irene Mattiola · 2023 · Frontiers in Oncology
60. The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
    Sarah McCuaig, David Barras, Elizabeth H. Mann, Matthias Friedrich, Samuel J. Bullers, Alina Janney, Lucy C. Garner, Enric Domingo, Viktor Hendrik Koelzer, Mauro Delorenzi et al. · 2020 · Clinical Cancer Research
61. The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation
    P-S Liu, T-H Jong, M C Maa, Tzeng‐Horng Leu · 2010 · Oncogene
62. Activation Status of the JAK/STAT3 Pathway in Mantle Cell Lymphoma
    Marwan A. Yared, Joseph David Khoury, Leonard Jeffrey Medeiros, George Z. Rassidakis, Raymond L. Lai · 2005 · Archives of Pathology & Laboratory Medicine
63. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling
    Jino Park, Soo‐Jin Kim, Joongho J. Joh, Scot C. Remick, Donald Max Miller, Jun Yan, Zeyad Kanaan, Ju-Hsien Chao, Maxwell M. Krem, Soumit K. Basu et al. · 2016 · Oncotarget
64. Taking the Myc is bad for Theileria
    Frédéric Dessauge, Regina Lizundia, Martin Baumgartner, Marie Chaussepied, Gordon Langsley · 2005 · Trends in Parasitology
65. Endogenously activated mGlu5 metabotropic glutamate receptors sustain the increase in c‐Myc expression induced by leukaemia inhibitory factor in cultured mouse embryonic stem cells
    Paola Spinsanti, Teresa De Vita, Sara Di Castro, Marianna Storto, Pietro Formisano, Ferdinando Nicoletti, Daniela Melchiorri · 2006 · Journal of Neurochemistry
66. SOCS3 was induced by hypoxia and suppressed STAT3 phosphorylation in pulmonary arterial smooth muscle cells
    Bai Li, Zubin Yu, Guisheng Qian, Pin Qian, Jinjun Jiang, Guansong Wang, Chunxue Bai · 2005 · Respiratory Physiology & Neurobiology
67. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3
    Carmit Levy, Yu Nee Lee, Hovav Nechushtan, Ora Schueler‐Furman, Amir Sonnenblick, Shelley Hacohen, Ehud Razin · 2005 · Blood
68. Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy
    Martine Szyper‐Kravitz, Orit Uziel, Hava Shapiro, Judith Radnay, Tami Katz, Jacob M. Rowe, Michael Lishner, Meir Lahav · 2003 · British Journal of Haematology
69. Protective effects of an electrophilic metabolite of docosahexaenoic acid on UVB-induced oxidative cell death, dermatitis, and carcinogenesis
    Seong Hoon Kim, So Eui Lee, Su‐Jung Kim, Xizhu Fang, Jihyeon Hur, Erdi Sözen, Nesrin Kartal Özer, Kwang Pyo Kim, Young‐Joon Surh · 2023 · Redox Biology
70. ZO-1 Regulates Erk, Smad1/5/8, Smad2, and RhoA Activities to Modulate Self-Renewal and Differentiation of Mouse Embryonic Stem Cells
    Jianliang Xu, Sophia Beng Hui Lim, Mei Yong Ng, Safiah Mohamed Ali, Jaya P. Kausalya, Vachiranee Limviphuvadh, Sebastian Maurer‐Stroh, Walter Hunziker · 2012 · Stem Cells
71. Novel small molecule, XZH‐5, inhibits constitutive and interleukin‐6‐induced STAT3 phosphorylation in human rhabdomyosarcoma cells
    Aiguo Liu, Yan Liu, Zhenghu Xu, Wenying Yu, Hong Wang, Chenglong Li, Jiayuh Lin · 2011 · Cancer Science
72. Inflammation in Urological Malignancies: The Silent Killer
    Martina Catalano, Giandomenico Roviello, Raffaella Santi, Donata Villari, Pietro Spatafora, Ilaria Camilla Galli, Francesco Sessa, Francesco Lupo Conte, Enrico Mini, Tommaso Cai et al. · 2023 · International Journal of Molecular Sciences
73. Targeting angiogenesis in gliomas: Potential role of phytochemicals
    Mehdi Sanati, Amir R. Afshari, Javad Amini, Hamid Mollazadeh, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2022 · Journal of Functional Foods
74. New Functions for PI3K in the Control of Cell Division
    Amit Kumar, Ana Clara Carrera · 2007 · Cell Cycle
75. T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer
    Satomi Watanabe, Takeshi Yoshida, Hisato Kawakami, Naoki Takegawa, Junko Tanizaki, Hidetoshi Hayashi, Masayuki Takeda, Kimio Yonesaka, Junji Tsurutani, Kazuhiko Nakagawa · 2017 · Molecular Cancer Therapeutics
76. The platelet-derived growth factor system in renal disease: An emerging role of endogenous inhibitors
    Claudia R.C. van Roeyen, Tammo Ostendorf, Jürgen Floege · 2011 · European Journal of Cell Biology
77. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
    S. Kalakonda, S. Nallar, P. Gong, D. Lindner, S. Goldblum, S. Reddy, D. Kalvakolanu · 2007 · American Journal of Pathology
78. Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
    Ebba Palmberg, John Inge Johnsen, Janna Paulsson, Helena Gleissman, Malin Wickström, Margareta Edgren, Arne Östman, Per Kogner, Magnus Lindskog · 2008 · International Journal of Cancer
79. Increased metastasis with loss of E2F2 in Myc-driven tumors
    Inez Yuwanita, Danielle Barnes, Michael D. Monterey, Sandra O’Reilly, Eran R. Andrechek · 2015 · Oncotarget
80. IκB kinase‐α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage‐based anticancer therapy
    Irene Pecharromán, Laura Solé, Daniel Alvarez Villanueva, Teresa Lobo‐Jarne, Josune Alonso‐Marañón, Joan Bertran, Yolanda Guillén, Ángela Montoto, María Martínez‐Iniesta, Violeta García‐Hernández et al. · 2023 · The EMBO Journal
81. Epigenetic Component p66a Modulates Myeloid-Derived Suppressor Cells by Modifying STAT3
    Jiaxuan Xin, Zhiqian Zhang, Xiaomin Su, Liyang Wang, Yuan Zhang, Rongcun Yang · 2017 · The Journal of Immunology
82. Clinicopathological and Prognostic Role of STAT3/p-STAT3 in Breast Cancer Patients in China: A Meta-Analysis
    Yang Li, Yue Wang, Zhixiang Shi, Jinghan Liu, Shuyun Zheng, Jinsong Yang, Yi Liu, Yuhua Yang, Feng Chang, Wenying Yu · 2019 · Scientific Reports
83. The Use of Gene Expression Analysis to Gain Insights into Signaling Mechanisms of Metastatic Medulloblastoma
    Arun Chopra, Kevin M. Brown, Brian R. Rood, Roger J. Packer, Tobey J. MacDonald · 2003 · Pediatric Neurosurgery
84. JAK-STAT pathway activation in response to spinal cord injury in regenerative and non-regenerative stages of Xenopus laevis
    Víctor S. Tapia, Mauricio Herrera-Rojas, Juan Larraı́n · 2017 · Regeneration
85. TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways
    Santina Venuto, Stefano Castellana, Maria Monti, Irene Appolloni, Caterina Fusilli, Carmela Fusco, Piero Pucci, Paolo Malatesta, Tommaso Mazza, Giuseppe Merla et al. · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
86. SRC and STAT Pathways
    Eric B. Haura · 2006 · Journal of Thoracic Oncology
87. Cytoplasmic c‐Fos induced by the YXXQ‐derived STAT3 signal requires the co‐operative MEK/ERK signal for its nuclear translocation
    Natsuko Higashi, Hiroyuki Kunimoto, Shuhei Kaneko, Takanori Sasaki, Masamitsu Ishii, Hirotada Kojima, Koichi Nakajima · 2004 · Genes to Cells
88. Approaches for targeting cancer stem cells drug resistance
    Roberta Rosa, Valentina D’Amato, Sabino De Placido, Roberto Bianco · 2016 · Expert Opinion on Drug Discovery
89. DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and Kaposi sarcoma herpesvirus replication
    Andrea Arena, Maria Saveria Gilardini Montani, Maria Anele Romeo, Rossella Benedetti, Aurelia Gaeta, Mara Cirone · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
90. Role of signal transducer and activator of transcription 3 (STAT3) in stretch injury to bladder smooth muscle cells
    Sarel Halachmi, KAREN J. AITKEN, Marta Szybowska, Nesrin Sabha, Shariff Dessouki, Armando José Lorenzo, Derrick Tse, Darius Bägli · 2006 · Cell and Tissue Research
91. Requirements of Src family kinase during meiotic maturation in mouse oocyte
    Ke‐Gang Zheng, Xiaoqian Meng, Yong Guang Yang, Yuansong Yu, D. W. Liu, Yunlong Li · 2006 · Molecular Reproduction and Development
92. Neoplastic transformation by the gep oncogene, Gα12, involves signaling by STAT3
    Rashmi N. Kumar, Scott K. Shore, N. Dhanasekaran · 2005 · Oncogene
93. Critical analysis of the potential for targeting STAT3 in human malignancy
    Grandis, Jennifer, Peyser · 2013 · OncoTargets and Therapy
94. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner
    Wanli Zhai, Xiongjun Ye, Yinyin Wang, Yarui Feng, Ying Wang, Yu-Ting Lin, Lidan Ding, Yang Liu, Xuning Wang, Yanshen Kuang et al. · 2021 · British Journal of Cancer
95. Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?
    Manxi Ge, Yan Zhu, Minjie Wei, Haozhe Piao, Miao He · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
96. Activation of Stat3 Transcription Factor by Herpesvirus Saimiri STP-A Oncoprotein
    Young-Hwa Chung, Nam‐Hyuk Cho, Maria Ines Garcia, Sun Hwa Lee, Pinghui Feng, Jae Ung Jung · 2004 · Journal of Virology
97. Transcriptional Activation of the Suppressor of Cytokine Signaling-3 (SOCS-3) Gene via STAT3 Is Increased in F9 REX1 (ZFP-42) Knockout Teratocarcinoma Stem Cells Relative to Wild-type Cells
    Juliana Xu, Renia Sylvester, Ann P. Tighe, Siming Chen, Lorraine J. Gudas · 2008 · Journal of Molecular Biology
98. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells
    Teresa Robledo, Lourdes Arriaga‐Pizano, Mario Lopez-Pérez, Eduardo Pérez Salazar · 2005 · Matrix Biology
99. Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis
    Linhong Liu, Xu Li, Ying Chen, Yi-Zhe Li, Zhen Liu, Yu Duan · 2023 · Journal of Maternal-Fetal & Neonatal Medicine
100. Cross-talk between myeloid-derived suppressor cells and Mucin1 in breast cancer vaccination: On the verge of a breakthrough
     Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Behzad Baradaran · 2020 · Life Sciences